Printer Friendly

COMPANY INFORMATION
Angiotech Pharmaceuticals, Inc. 1618 Station St Vancouver, BC V6A 1B6 Tel: (604) 221-7676 Fax: (604) 221-2330 Contact Name Rick Smith FP 500 2010 Ranking FP 500 - Sales: 529; Assets: 481; Income: 520 Industry Biotechnology		Key Executives William L. Hunter, CEO K. Thomas Bailey, CFO Develops and commercializes medical device coatings and treatments for chronic inflammatory diseases through the combination of pharmaceutical compounds with medical devices and biomaterials. Also manufactures and sells single-use medical products and medical device components. Lead products include TAXUS® paclitaxel-eluting coronary stent systems, Quill™ SRS barbed sutures, SKATER™ drainage catheters, Option™ Inferior Vena Cava filters and HemoStream™ dialysis catheters.
FP ADVISOR COVERAGE Angiotech Pharmaceuticals, Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • Ordering FP Products		TOP INDUSTRY PLAYERS Biotechnology Company Name Revenue ($000s)  Atrium Innovations Inc. 364,726 Angiotech Pharmaceuticals, Inc. 319,113 AEterna Zentaris Inc. 72,153 QLT Inc. 48,042 GLG Life Tech Corporation 41,884 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF JULY 29/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/ANP NASDAQ/ANPI $0.61 $2.26 on Aug. 11/09 $0.59 on July 22/10 n.a. n.a. n.a. 3.75 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap (000s) 54,982 n.a. US$ -0.50 Mar. 31/10 -64.53% -56.62% -48.34% $51,954
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/09 12m Dec. 31/08 12m Dec. 31/07 US$000s US$000s US$000s Operating revenue 279,678 283,272 287,694 Net income (22,868) (741,176) (65,940) Total assets 370,059 385,197 1,150,108 US$ US$ US$ Earnings per share* (0.27) (8.71) (0.78) % % % Return on equity n.m. n.m. (12.12)   * Common A Reported in accordance with U.S. GAAP
TRAILING 12-MONTH VALUES Periods ended: Mar. 31/10 Mar. 31/09 US$000s US$000s Operating revenue 254,719 294,864 Net income (42,007) (712,969) US$ US$ Earnings per share (0.49) (8.37)   A Reported in accordance with U.S. GAAP

COMPANY NEWS

Results for 'Angiotech Pharmaceuticals, Inc.' from past 30 days: No hits. (Links are to articles.)